Traders should monitor the March 30 earnings call for updates on revenue, R&D progress, cash runway, and pipeline developments, which could move the stock given the company's small market cap ($121M).
Price Chart
Executive Summary
Sangamo Therapeutics announced it will release its Q4 and full-year 2025 financial results on March 30, 2026, followed by a conference call to review the results and provide business updates. The press release contains no actual financial data, only logistical details about the earnings announcement.
Key Facts
- Sangamo Therapeutics will release Q4 and full-year 2025 financial results after market close on March 30, 2026.
- A conference call is scheduled for 4:30 p.m. Eastern on the same day to discuss results and business updates.
- No financial figures, guidance, or operational updates were disclosed in this press release.
Financial Impact
No financial data disclosed — impact will depend on actual earnings release
Risk Factors
- High volatility expected post-earnings due to small market cap and lack of current revenue-generating products.
- No financial or operational metrics provided in this release — actual results may differ significantly from expectations.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3259419 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 1, 2026 13w ago | 8-K | $0.0740 awaiting T+20 | awaiting T+20 | — | — |
Apr 29, 2026 22w ago | 8-K | $0.1300 $0.2000 | ▼ −53.85% | ▼ −48.39% | — |
Apr 21, 2026 23w ago | Insider Cluster | $0.2600 $0.1300 | ▼ −50.00% | ▼ −54.91% | — |
Mar 30, 2026 26w ago | Press Release | $0.2500 $0.1387 | ▼ −44.52% | ▼ −53.94% | — |
Mar 19, 2026 28w ago | Press Release | $0.3300 $0.2700 | ▼ −18.18% | ▼ −27.50% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access